James Jones - 14 Apr 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
James Jones by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
14 Apr 2022
Net transactions value
+$830
Form type
4
Filing time
06 May 2022, 17:08:53 UTC
Previous filing
29 Apr 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $75.88 +28 +0.14% $2.71 20,393 14 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $73.64 +28 +0.14% $2.63 20,421 18 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $75.32 +28 +0.14% $2.69 20,449 19 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $76.72 +28 +0.14% $2.74 20,477 20 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $77 +28 +0.14% $2.75 20,505 21 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $76.44 +28 +0.14% $2.73 20,533 22 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $78.6 +30 +0.15% $2.62 20,563 25 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $75.9 +30 +0.15% $2.53 20,593 26 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $72.3 +30 +0.15% $2.41 20,623 27 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $75.3 +30 +0.15% $2.51 20,653 28 Apr 2022 Direct F1
transaction CPIX Common Stock Purchase $73.2 +30 +0.15% $2.44 20,683 29 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.